Skip to main content
SpringerLink
Log in

Nanotechnology and Diabetes Management: Recent Advances and Future Perspectives

  • Chapter
  • First Online:
Book cover Application of Nanotechnology in Biomedical Sciences

Abstract

Nanotechnology brings us easy to operate equipment’s, especially in the form of lab-on-a-chip, to analyze different ailments with incredible accuracy, instant results, and offers point-of-care testing. Nanotechnology is now capable of fulfilling our needs (almost), impact areas of current and future diabetes research. It has shown promising results in the treatment of diabetes by improving the efficacy of existing drugs, which holds the potential of dramatically improving the quality life of diabetic patients. Nanoparticles, due to shape-dependent properties, especially in which at least one dimension is less than 100 nm, serve as potential drug delivery systems in the areas where there are barriers or unfavorable environments for macromolecules, to deliver the drugs efficiently. Moreover, nanomaterials in the form of polymers, inhalable formulations, ceramic, gold, silver, and insulin delivery using BioMEMS are nowadays used as carriers in the delivery of drugs. This technology offers implantable or wearable sensors that provide continuous and accurate medical information. This chapter deals with the potential applications of nanoparticles, BioMEMS, recent advances, and impact on biomedical sciences in the treatment of diabetes. Furthermore, this chapter brings together some latest advancements of nanotechnology, such as the development of the artificial pancreas and smart cells.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • American DA (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33:S62

    Google Scholar 

  • Alanazi NH, Alsharif MM, Rasool G, Alruwaili ABH, Alrowaili AMZ, Aldaghmi AS, Al Shkra MKD, Alrasheedi FA, Alenezi GS, Alanazi MT (2017) Prevalence of diabetes and its relation with age and sex in Turaif city, northern Saudi Arabia in 2016–2017. Electron Physician 9:5294

    Google Scholar 

  • Albisser A, Leibel B, Ewart T, Davidovac Z, Botz C, Zingg W (1974) An Artificial endocrine pancreas. Diabetes 23:389

    Google Scholar 

  • Arya AK, Kumar L, Pokharia D, Tripathi K (2008) Applications of nanotechnology in diabetes. Dig J Nanomater Biostruct 3:221

    Google Scholar 

  • Attivi D, Wehrle P, Ubrich N, Damge C, Hoffman M, Maincent P (2005) Formulation of insulin-loaded polymeric nanoparticles using response surface methodology. Drug Dev Ind Pharm 31:179

    Google Scholar 

  • Babu VR, Patel P, Mundargi RC, Rangaswamy V, Aminabhavi TM (2008) Developments in polymeric devices for oral insulin delivery. Expert Opin Drug Deliv 5:403

    Google Scholar 

  • Berenson DF, Weiss AR, Wan ZL, Weiss MA (2011) Insulin analogs for the treatment of diabetes mellitus: therapeutic applications of protein engineering. Ann N Y Acad Sci 1243:E40–E54

    Google Scholar 

  • Bhumkar DR, Joshi HM, Sastry M, Pokharkar VB (2007) Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin. Pharm Res 24:1415

    Google Scholar 

  • Brigger I, Dubernet C, Couvreur P (2012) Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev 64:24

    Google Scholar 

  • Carino GP, Mathiowitz E (1999) Oral insulin delivery. Adv Drug Deliv Rev 35:249

    Google Scholar 

  • Cherian AK, Rana A, Jain SK (2000) Self-assembled carbohydrate-stabilized ceramic nanoparticles for the parenteral delivery of insulin. Drug Dev Ind Pharm 26:459

    Google Scholar 

  • Cho K, Wang X, Nie S, Shin DM (2008) Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res 14:1310

    Google Scholar 

  • Corkery K (2000) Inhalable drugs for systemic therapy. Respir Care 45:831

    Google Scholar 

  • Cui F, Qian F, Zhao Z, Yin L, Tang C, Yin C (2009) Preparation, characterization, and oral delivery of insulin loaded carboxylated chitosan grafted poly(methyl methacrylate) nanoparticles. Biomacromolecules 10:1253

    Google Scholar 

  • Di J, Price J, Gu X, Jiang X, Jing Y, Gu Z (2014) Ultrasound-triggered regulation of blood glucose levels using injectable nano-network. Adv Healthc Mater 3:811

    Google Scholar 

  • Donath MY, Shoelson SE (2011) Type 2 Diabetes as an inflammatory disease. Nat Rev Immunol 11:98

    Google Scholar 

  • Douglas S, Davis S, Illum L (1987) Nanoparticles in drug delivery. Crit Rev Ther Drug Carrier Syst 3:233

    Google Scholar 

  • Drucker DJ, Dritselis A, Kirkpatrick P (2010) Liraglutide. Nat Rev Drug Discov 4:267

    Google Scholar 

  • Dykes GM (2001) Dendrimers: a review of their appeal and applications. J Chem Technol Biotechnol 76:903

    Google Scholar 

  • Erin M (2010) Health Tech Zone. Med Feat Art 2:2

    Google Scholar 

  • Gough DA, Kumosa LS, Routh TL, Lin JT, Lucisano JY (2010) Function of an implanted tissue glucose sensor for more than 1 year in animals. Sci Transl Med 2:42ra53

    Google Scholar 

  • Hampton T (2018) Smart artificial beta cells may help treat diabetes. JAMA 319:11

    Google Scholar 

  • Harsoliya MS, Patel VM, Modasiya M, Pathan JK, Chauhan A, Parihar M, Ali M (2012). Recent advances & applications of nanotechnology in diabetes. Int J Pharm Biol Archiv 3:255

    Google Scholar 

  • Heinemann L (2011) New ways of insulin delivery. Int J Clin Pract 65:31

    Google Scholar 

  • http://thefutureofthings.com/news/1286/insulin-nanopump-for-accuratedrug-delivery.html (2018)

  • http://www.innovationtoronto.com/2015/06/smart-insulin-patch-could-replace-painful-injections-for-diabetes/ (2018)

  • https://medicalfuturist.com/living-with-an-artificial-pancreas/

  • https://www.medgadget.com/2007/04/debiotechs_insulin_nanopump.html (2018)

  • https://www.nextbigfuture.com/2008/04/microphysiometer-using-multiwall-carbon.html

  • Ilium L (1998) Chitosan and its use as a pharmaceutical excipient. Pharm Res 15:1326

    Google Scholar 

  • Ismail-Beigi F (2012) Glycemic management of type 2 diabetes mellitus. N Engl J Med 366:1319

    Google Scholar 

  • Kalomiraki M, Thermos K, Chaniotakis NA (2016) Dendrimers as tunable vectors of drug delivery systems and biomedical and ocular applications. Int J Nanomedicine 11:1

    Google Scholar 

  • Kannan R, Nance E, Kannan S, Tomalia DA (2014) Emerging concepts in dendrimer‐based nanomedicine: from design principles to clinical applications. J Intern Med 276:579

    Google Scholar 

  • Karolczak K, Rozalska S, Wieczorek M, Labieniec-Watala M, Watala C (2012) Poly(amido) amine dendrimers generation 4.0 (PAMAM G4) reduce blood hyperglycaemia and restore impaired blood–brain barrier permeability in streptozotocin diabetes in rats. Int J Pharm 436:508

    Google Scholar 

  • Kawashima Y, Yamamoto H, Takeuchi H, Fujioka S, Hino T (1999) Pulmonary delivery of insulin with nebulized DL-lactide/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effect. J Control Release 62:279

    Google Scholar 

  • Kesharwani P, Jain K, Jain NK (2014) Dendrimer as nanocarrier for drug delivery. Prog Polym Sci 39:268

    Google Scholar 

  • Kralj M, Pavelic K (2003) Medicine on a small scale: how molecular medicine can benefit from self-assembled and nanostructured materials. EMBO Rep 4:1008

    Google Scholar 

  • Logothetidis S (2006) Nanotechnology in medicine: the medicine of tomorrow and nanomedicine. Hippokratia 10:7

    Google Scholar 

  • Martinac K, Metelko Z (2005) Nanotechnology and diabetes. Diabetol Croat 34:105

    Google Scholar 

  • McConnell HM, Owicki JC, Parce JW, Miller D, Baxter GS, Wada HG, Pitchford S (1992) The cytosensor microphysiometer: biological applications of silicon technology. Science 257:1906

    Google Scholar 

  • Meier JJ, Nauck MA (2008) Is secretion of glucagon-like peptide-1 reduced in type 2 diabetes mellitus?. Nat Rev Endocrinol 4:606

    Google Scholar 

  • Morçöl T, Nagappan P, Nerenbaum L, Mitchell A, Bell S (2004) Calcium phosphate-PEG-insulin-casein (CAPIC) particles as oral delivery systems for insulin. Int J Pharm 277:91

    Google Scholar 

  • Morishita I, Morishita M, Takayama K, Machida Y, Nagai T (1992) Hypoglycemic effect of novel oral microspheres of insulin with protease inhibitor in normal and diabetic rats. Int J Pharm 78:9

    Google Scholar 

  • Naesens M, Sarwal MM (2010) Molecular diagnostics in transplantation. Nat Rev Nephrol 6:614

    Google Scholar 

  • Paul W, Sharma CP (2001) Porous hydroxyapatite nanoparticles for intestinal delivery of insulin. Trends Biomater Artif Organs 14:37

    Google Scholar 

  • Paul W, Sharma CP (2008) Tricalcium phosphate delayed release formulation for oral delivery of insulin: a proof-of-concept study. J Pharm Sci 97:875

    Google Scholar 

  • Plapied L, Duhem N, des Rieux A, Préat V (2011) Fate of polymeric nanocarriers for oral drug delivery. Curr Opin Colloid Interface Sci 16:228

    Google Scholar 

  • Roco M, Williams R, Alivisatos P (2000) Biological, medical and health applications. “Nanotechnology research directions,” Chap. 8. Kluwer Academic Publishers, Boston

    Google Scholar 

  • Roy I, Ohulchanskyy TY, Pudavar HE, Bergey EJ, Oseroff AR, Morgan J, Dougherty TJ, Prasad PN (2003) Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy. J Am Chem Soc 125:7860

    Google Scholar 

  • Russell SJ, El-Khatib FH, Sinha M, Magyar KL, McKeon K, Goergen LG, Balliro C, Hillard MA, Nathan DM, Damiano ER (2014) Outpatient glycemic control with a bionic pancreas in type 1 diabetes. N Engl J Med 371:313

    Google Scholar 

  • Sahoo SK, Labhasetwar V (2003) Nanotech approaches to drug delivery and imaging. Drug Discov Today 8:1112

    Google Scholar 

  • Sarmento B, Ribeiro A, Veiga F, Sampaio P, Neufeld R, Ferreira D (2007) Alginate/chitosan nanoparticles are effective for oral insulin delivery. Pharm Res 24:2198

    Google Scholar 

  • Schiemann G (2006) Nanotechnology challenges: implications for philosophy, ethics and society. World Scientific, London, p 73

    Google Scholar 

  • Selvaraj K, Gowthamarajan K, Karri VVSR, Barauah UK, Ravisankar V, Jojo GM (2017) Current treatment strategies and nanocarrier based approaches for the treatment and management of diabetic retinopathy. J Drug Target 25:386

    Google Scholar 

  • Si P-Z, Zhang Z-D, Geng D-Y, You C-Y, Zhao X-G, Zhang W-S (2003) Synthesis and characteristics of carbon-coated iron and nickel nanocapsules produced by arc discharge in ethanol vapor. Carbon 41:247

    Google Scholar 

  • Subramani K, Pathak S, Hosseinkhani H (2012) Recent Trends in diabetes treatment using nanotechnology. Dig J Nanomater Biostruct 7:85–95

    Google Scholar 

  • Tao SL, Desai TA (2003) Microfabricated drug delivery systems: from particles to pores. Adv Drug Deliv Rev 55:315

    Google Scholar 

  • Tekade RK, Kumar PV, Jain NK (2008) Dendrimers in oncology: an expanding horizon. Chem Rev 109:49

    Google Scholar 

  • Tolia GT, Choi HH (2008) The role of dendrimers in topical drug delivery. Pharm Technol 32:88

    Google Scholar 

  • Tsapis N, Bennett D, Jackson B, Weitz DA, Edwards D (2002) Trojan particles: large porous carriers of nanoparticles for drug delivery. Proc Natl Acad Sci 99:12001

    Google Scholar 

  • Veiseh O, Tang BC, Whitehead KA, Anderson DG, Langer R (2015) Managing diabetes with nanomedicine: challenges and opportunities. Nat Rev Drug Discov 14:45

    Google Scholar 

  • Vollath D, Szabo DV, Hauβelt J (1997) Synthesis and properties of ceramic nanoparticles and nanocomposites. J Eur Ceram Soc 17:1317

    Google Scholar 

  • Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, Carter A, Casey DC, Charlson FJ, Chen AZ (2016) Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet 388:1545

    Google Scholar 

  • Weissleder R, Pittet MJ (2008) Imaging in the era of molecular oncology. Nature 452:580

    Google Scholar 

  • Woldu MA, Lenjisa JL (2017) Nanoparticles and the new era in diabetes management. Int J Basic Clin Pharmacol 3:277

    Google Scholar 

  • Yang H, Sun X, Liu G, Ma R, Li Z, An Y, Shi L (2013) Glucose-responsive complex micelles for self-regulated release of insulin under physiological conditions. Soft Matter 9:8589

    Google Scholar 

  • Yih T, Al-Fandi M (2006) Engineered nanoparticles as precise drug delivery systems. J Cell Biochem 97:1184

    Google Scholar 

Download references

Acknowledgments

The Department of Science and Technology, Government of India, Nano Mission, under Grant SR/NM/NB-1038/2016, supported this work.

Author information

Authors and Affiliations

  1. Department of Pharmaceutical Sciences, University of Kashmir, Srinagar, Jammu and Kashmir, India

    Rumaisa Rashid, Amreen Naqash & Ghulam Nabi Bader

  2. Department of Nanotechnology, University of Kashmir, Srinagar, Jammu and Kashmir, India

    Faheem A. Sheikh

Authors
  1. Rumaisa Rashid
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amreen Naqash
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ghulam Nabi Bader
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Faheem A. Sheikh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Faheem A. Sheikh .

Editor information

Editors and Affiliations

  1. Department of Nanotechnology, University of Kashmir, Srinagar, Jammu and Kashmir, India

    Faheem A. Sheikh

Rights and permissions

Reprints and permissions

Copyright information

© 2020 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Rashid, R., Naqash, A., Bader, G.N., Sheikh, F.A. (2020). Nanotechnology and Diabetes Management: Recent Advances and Future Perspectives. In: Sheikh, F. (eds) Application of Nanotechnology in Biomedical Sciences. Springer, Singapore. https://doi.org/10.1007/978-981-15-5622-7_6

Download citation

Publish with us

Policies and ethics

Search

Navigation